Article ; Online: Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factors.
Internal medicine (Tokyo, Japan)
2011 Volume 50, Issue 22, Page(s) 2793–2800
Abstract: Objective: The aim of this study was to evaluate the adherence of guidelines for the management and treatment of glucocorticoid-induced osteoporosis, and to investigate whether it is associated with factors such as age, gender, glucocorticoid dose, ... ...
| Abstract | Objective: The aim of this study was to evaluate the adherence of guidelines for the management and treatment of glucocorticoid-induced osteoporosis, and to investigate whether it is associated with factors such as age, gender, glucocorticoid dose, physician specialty, and size of facility. Methods: This was a cross-sectional study utilizing administrative data from a database of health insurance claims (2004-2007); 2,368 patients who received glucocorticoid treatment for ≥90 days were extracted. The guideline adherence was determined by evaluations based on glucocorticoid prescription dose, prescription of anti-osteoporosis drugs, and whether or not bone mineral density was measured. Results: Overall proportion of guideline adherence was 23.3%. In cases in which the equivalent dose of prednisolone was <5 mg/d and ≥5 mg/d, the adherence was 8.3% and 30.5% respectively. Factors correlating with low adherence included young age, male gender, and lower glucocorticoid doses. Surgery and otolaryngology specialties had lower adherence than internal medicine. Smaller clinical facilities had lower adherence than larger facilities. Conclusion: The adherence of guidelines for the management and treatment of glucocorticoid-induced osteoporosis is still low, and improvements in treatment quality can be expected through education of patient groups and medical care providers with large deviations from the guidelines. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Adult ; Aged ; Aged, 80 and over ; Bone Density/drug effects ; Bone Density Conservation Agents/therapeutic use ; Cross-Sectional Studies ; Disease Management ; Female ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Guideline Adherence ; Humans ; Male ; Middle Aged ; Osteoporosis/chemically induced ; Osteoporosis/drug therapy ; Osteoporosis/metabolism ; Practice Guidelines as Topic ; Young Adult | |||||
| Chemical Substances | Bone Density Conservation Agents ; Glucocorticoids | |||||
| Language | English | |||||
| Publishing date | 2011-11-15 | |||||
| Publishing country | Japan | |||||
| Document type | Journal Article ; Research Support, Non-U.S. Gov't | |||||
| ZDB-ID | 32371-8 | |||||
| ISSN | 1349-7235 ; 0021-5120 ; 0918-2918 | |||||
| ISSN (online) | 1349-7235 | |||||
| ISSN | 0021-5120 ; 0918-2918 | |||||
| DOI | 10.2169/internalmedicine.50.5266 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 240: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.